参考文献/References:
[1] Pickett B,Pouliot J.The effect of the radial function on 1-125 seeds used for permanent prostate implantation.Med Dosim,2004,29(3):204-209.
[2] 陈强,沈金贵,夏泽斌,等.125I近距离插植放疗治疗前列腺癌.现代实用医学,2005,17(5):271-273.
[3] Whitmore WF Jr,Hilaris B,Grabstald H.Retropubic implantation of iodine 125 in the treatment of prostatic cancer.1972.J Ural,2002,167(2Pt2):981-983.
[4] Langley SE,Laing RW.Iodine seed prostate brachytherapy:an alternative first-line choice for early prostate cancer.Prostate Cancer Prostatic Dis,2004,7(3):201-207.
[5] 申文江.放射性粒子植人的现状与进展.中国微创外科杂志,2007,7(2):118-119.
[6] 宋刚,周利群.前列腺癌放射性粒子近距离治疗[J/OL].中华临床医师杂志(电子版),2009,3(4):16-18[2012-07-19].http://www.cqvip.com/Main/Detail.aspx?id=30248857.
[7] 曲昂,王俊杰.前列腺癌近距离治疗进展.癌症进展,2010,8(4); 361-365.
[8] 顾建平,何旭,陈亮,等.超选择性支气管动脉栓塞化疗治疗肺癌.中华放射学杂志,2003,37(10):908-911.
[9] 柴树德,郑广钧,毛玉权,等.CT引导下经皮穿刺种植放射性125I粒子治疗晚期肺癌.中华放射肿瘤学杂志,2004,13(4):291-293.
[10] 石树远,梁吉祥,郑广钧,等.缓释氟尿嘧啶与缓释顺祐粒子联合125I粒子治疗肺癌.医学综述,2009,15(10):1575-1577.
[11] 张福君,吴沛宏,顾仰葵,等.CT导向下125I粒子植人治疗肺转移瘤.中华放射学杂志,2004,38(9):906-909.
[12] 田桂源,张蕾.CT导向下125I粒子组织间植入治疗非小细胞肺癌.介入放射学杂志,2009,18(9):704-707.
[13] 夏金堂,林帆,温敏杰.肝癌术后局部化疗对复发的影响.广州医学院学报,2002,30(4):57.
[14] 林俊清,杨维竹,江娜,等.CT引导下125I放射性粒子植入治疗原发性肝细胞癌伴门静脉癌栓.中国介入影像与治疗学,2011,8(4):299-302.
[15] 罗开元,郑江华,李波,等.125I粒子永久性植入组织间放射治疗肝癌.肝胆胰外科杂志,2004,16(1):29-31.
[16] 任大力,陈启龙.胰腺癌介入治疗展望.现代肿瘤医学,2009,17(9):1820-1822.
[17] 张丽云,王忠敏,陈克敏,等.103Pd粒子组织间植入治疗恶性肿瘤的研究进展.介入放射学杂志,2009,18(10):789-792.
[18] 周毅,蒋忠仆,王海亭,等.PET-CT引导在放射性粒子植入治疗肺癌中的价值.介入放射学杂志,2010,19(5):389-391.
[19] 邢刚,柴树德,郭德安,等.MRI靶区定位在不张型肺癌125I粒子植入治疗中的应用.实用放射学杂志,2011,27(7):1021-1024.
[20] 柴树德,郑广钧,毛玉权,等.纤维支气管镜下125I粒子植入治疗大气管肺癌.中国肿瘤影像与微创治疗杂志,2003,1(2):23-26.
[21] 林征宇,林军,陈少明,等.1.5T MRI引导125I粒子组织间插植治疗恶性肿瘤的可行性.中国介入影像与治疗学,2011,8(1):5-9.
[22] 杨景魁,柴树德,郑广钧,等.125I放射性粒子支架治疗食管癌性狭窄的临床观察.肿瘤防治杂志,2004,11(5):32-34.
[23] 王俊杰.放射性粒子植人治疗肿瘤.当代医学,2009,15(29):632-634.
[24] 杨瑞杰,王俊杰,杨瑞学.放射性粒子植入计划系统剂量计算准确性验证.中华放射医学与防护杂志,2011,31(4):493-495.
[25] 张建波,王建华,王娟.影响放射性粒子植入临床疗效的因素.国际肿瘤学杂志,2010,37(2):125-127.
[26] 王忠敏,黄钢,陈克敏,等.放射性粒子组织间植入治疗技术指南的建议.介入放射学杂志,2009,18(9):641-644.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[3]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[4]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[5]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[6]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[7]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[8]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[9]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[10]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[11]郭艾楠,魏玲格,傅鹏.131I-肿瘤细胞核人鼠嵌合单克隆抗体治疗实体瘤的研究进展[J].国际放射医学核医学杂志,2013,37(2):120.[doi:10.3760/cma.j.issn.1673-4114.2013.02.015]
GUO Ai-nan,WEI Ling-ge,FU Peng.Advances on the treatment of solid tumor by 131I labeled mouse-human chimeric tumor necrosis therapy monoclanal antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):120.[doi:10.3760/cma.j.issn.1673-4114.2013.02.015]
[12]柳江燕,陈雪红,胡金贵,等.125Ⅰ粒子持续低剂量率杀伤肿瘤细胞体外实验研究进展[J].国际放射医学核医学杂志,2011,35(1):5.[doi:10.3760/cma.j.issn.1673-4114.2011.01.002]
LIU Jiang-yan,CHEN Xue-houg,HU Jin-gui,et al.Advances in the experimental study on continuous low-dose-rate irradiation by 125I seeds killing cancer cell in vitro[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):5.[doi:10.3760/cma.j.issn.1673-4114.2011.01.002]
[13]孙启和,孙彬,杨永青.术中125I粒子植入治疗肿瘤的临床应用[J].国际放射医学核医学杂志,2010,34(2):102.[doi:10.3760/cma.j.issn.1673-4114.2010.02.011]
SUN Qi-he,SUN Bin,YANG Yong-qing.The clinical application of 125I radionuclide implantation in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):102.[doi:10.3760/cma.j.issn.1673-4114.2010.02.011]
[14]张俊,刘增礼.钠碘转运体基因介导的肿瘤放射性核素治疗研究[J].国际放射医学核医学杂志,2008,32(1):8.
ZHA NG Jun,LIU Zeng-li.Sodium iodide symporter gene-mediated radionuclide therapy of tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):8.
[15]吴光,侯建全.125I-脱氧尿苷治疗恶性肿瘤的研究进展[J].国际放射医学核医学杂志,2008,32(1):27.
WU Guang,HOU Jian-quan.The therapeutic progression of 125I-UdR in malignant lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):27.
[16]荆宏雁.癌症手术治疗中放射性125I粒子源的应用[J].国际放射医学核医学杂志,2008,32(1):58.
[17]胡瑞,林军.125I粒子组织间植入近距离治疗恶性肿瘤[J].国际放射医学核医学杂志,2007,31(6):381.
HU Rui,LIN Jun.Brachytherapy of malignant tumors with interstitial implantation of 125I seed[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(2):381.
[18]陈志军,涂新华,周爱清,等.125I粒子组织间植入治疗2例恶性肿瘤放化疗失败病例临床分析[J].国际放射医学核医学杂志,2006,30(3):180.
CHEN Zhi-jun,TU Xin-hua,ZHOU Ai-qing,et al.Clinical analysis of 125I seed implants in worst-casts of the malignant tumors after radiography and chemotherapy.[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):180.
[19]于雷,陈红红,程文英,等.放射性籽源薄层片植入治疗肿瘤的研究进展[J].国际放射医学核医学杂志,2006,30(6):369.
YU Lei,CHEN Hong-hong,CHENG Wen-ying,et al.Progress of intraoperative brachytherapy using radioactive seeds plaque implants for tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):369.